TASIGNA 200MG
NILOTINIB
Reimbursement base
33.717,20 MAD
Active substance
NILOTINIB
What is this medicine?
Nilotinib is a kinase inhibitor used for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML).
Verified summary
NILOTINIB, CAPSULE, 200 MG, 1 BOITE 112 CAPSULE
Common uses
Treatment of newly diagnosed Ph+ CML in chronic phase for adult and pediatric patients (1 year and older), as well as adult and pediatric patients with Ph+ CML who are resistant or intolerant to prior therapies such as imatinib or other tyrosine-kinase inhibitors.
Class
Kinase inhibitor
Hospital price
33.717,20 MAD
Strength
200 MG
Form
CAPSULE
Presentation
1 BOITE 112 CAPSULE
Type
P
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 0,00 MAD